Molecular Partners Ag (MOLN) EPS (Basic) (2020 - 2026)
Molecular Partners Ag (MOLN) posted quarterly EPS (Basic) of -$0.0 for Q1 2026, up 17.82% year-over-year from -$0.0 in Q1 2025, and up 99.98% quarter-over-quarter from -$2.2 in Q4 2025.
Molecular Partners Ag (MOLN) EPS (Basic) (2020 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported EPS (Basic) for 7 consecutive years, with -$0.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 17.82% year-over-year to -$0.0; the TTM figure through Mar 2026 stood at -$2.2 (down 20.11% YoY), while the FY2025 annual figure was $2.7, down 43.24% from the prior year.
- EPS (Basic) improved to -$0.0 in Q1 2026 per MOLN's latest filing, from -$2.2 in the prior quarter.
- Across five years, EPS (Basic) topped out at $3.93 in Q4 2022 and bottomed at -$2.2 in Q4 2023.
- Historically, EPS (Basic) has averaged -$0.18 across 5 years, with a median of -$0.0 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) soared 830.17% — and 2023, when it slumped 274.91%.
- Molecular Partners Ag's EPS (Basic) stood at $3.93 in 2022, then tumbled by 155.92% to -$2.2 in 2023, then rose by 16.89% to -$1.83 in 2024, then slipped by 20.13% to -$2.2 in 2025, then surged by 99.98% to -$0.0 in 2026.
- Business Quant data shows MOLN's EPS (Basic) at -$0.0 in Q1 2026, -$2.2 in Q4 2025, and -$0.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | 0.18 |
| 10 | Molecular Partners Ag | 163.99 Mn | 163.99 Mn | - | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | -2.20 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -1.83 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -2.20 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -0.54 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 3.93 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | -0.14 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | -2.23 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | -1.24 |